DRD2

D(2) dopamine receptor · P14416 · DRD2 on Sugi Atlas →

758,281 patent compounds predicted against DRD2, 426,302 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
SCHEMBL8078 SCHEMBL8078 1.00 20/20
Aripiprazole Aripiprazole (SCHEMBL8255) 1.00 20/20
Aripiprazole Aripiprazole (SCHEMBL8044) 0.98 20/20
SCHEMBL8423 SCHEMBL8423 1.00 18/20
SCHEMBL7929 SCHEMBL7929 0.93 17/20
Ropinirole Ropinirole (SCHEMBL35212) 1.00 15/20
Haloperidol Haloperidol (SCHEMBL8264) 1.00 14/20
Risperidone Risperidone (SCHEMBL27911) 1.00 14/20
Moperone Moperone (SCHEMBL34340) 1.00 14/20
Trazodone Trazodone (SCHEMBL28167) 1.00 12/20
Ziprasidone Ziprasidone (SCHEMBL28028) 1.00 11/20
SCHEMBL6700 SCHEMBL6700 0.53 11/20
Clozapine Clozapine (SCHEMBL8397) 1.00 10/20
SCHEMBL33323 SCHEMBL33323 0.51 10/20
Bepotastine Bepotastine (SCHEMBL29459) 0.51 10/20
Prochlorperazine Prochlorperazine (SCHEMBL18429) 1.00 9/20
Amisulpride Amisulpride (SCHEMBL34126) 1.00 9/20
Fenoldopam Fenoldopam (SCHEMBL34250) 1.00 9/20
SCHEMBL8511 SCHEMBL8511 1.00 8/20
Amoxapine Amoxapine (SCHEMBL33950) 1.00 8/20

Clinical trials — most relevant to DRD2 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Identify Peripheral Biomarkers of Symptomatology, Neurocognitive Functions, and Medication Response in ADHD PHASE4UNKNOWN
Adjunct Treatment With Cariprazine for Adults With Attention-deficit/Hyperactivity Disorder PHASE4UNKNOWN
Dopamine Enhancement of Fear Extinction Learning in PTSD (1R21MH108753) PHASE4COMPLETED
Effects of Rasagiline on Sleep Disturbances in Parkinson's Disease PHASE4COMPLETED
A New Pharmacotherapy for Alcohol Dependence: Olanzapine PHASE3COMPLETED
New Treatment for Alcohol and Nicotine Dependence PHASE2/PHASE3COMPLETED
Examination of Bromocriptine on Homeostatic and Hedonic Mechanisms of Food Intake in Individuals at High Risk for T2DM PHASE3COMPLETED
D1 and D2 Dopamine Receptors in Gambling and Amphetamine Reinforcement PHASE2COMPLETED
Psychopharmacology for Cocaine Dependence - Buspirone PHASE2COMPLETED
Relationship Between D2 Receptors SPECT and the Apomorphine Test in Patients With OH Dependence (ALC-DRD2-APO) PHASE2UNKNOWN
Exploring Occupancy of Dopamine D3 Receptor by Buspirone in Humans Using PET PHASE1/PHASE2COMPLETED
Positron Emission Tomography Imaging of Dopamine Receptors Using the Tracer [11C]NNC-112 PHASE1COMPLETED
PET Imaging and Bariatric Surgery PHASE1COMPLETED
Brain Dopaminergic Signaling in Opioid Use Disorders EARLY_PHASE1COMPLETED
Functional Relevance of Dopamine Receptors in Healthy Controls and Patients With Schizophrenia: Characterization Through [11C]NNC-112 and [18F]Fallypride Positron Emission Tomography nanCOMPLETED
A Brain Imaging Study Into Nicotine Induced Dopamine Release in Cigarette Smokers. nanUNKNOWN
A Study on Risk Mutations of Vulnerability Genes of Schizophrenia nanUNKNOWN
A Combined Psycho-pharmacological and Brain Imaging Study of Human Sexuality nanSUSPENDED
Dopamine and Insulin Resistance nanCOMPLETED
Molecular Genetic Study of Schizophrenia: Parent-Offspring Trios nanCOMPLETED
Adjuvant Therapy With Pergolide in Treating Cognitive Deficits in Schizophrenia nanCOMPLETED
The Genetic Basis for Vulnerability to Substance Abuse nanCOMPLETED
Attention Deficit Hyperactivity Disorder: Nutrition and Environment nanUNKNOWN
The Effects of Pharmacotherapy on Brain Mechanisms Underlying Cocaine Dependence. nanSUSPENDED
A Positional Cloning Study on Schizophrenia nanCOMPLETED
Dopamine Receptor Imaging in Mood Disorders nanCOMPLETED
Tetrabenazine for Partial Responders nanCOMPLETED
A Nutritional Intervention for Diabetic Neuropathy nanCOMPLETED
A Nutritional Intervention for Diabetic Neuropathy (WCCR-DN2) nanCOMPLETED
Human Adaptation to High Altitude nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a DRD2 binder may also engage these)

ProteinNameSimilarity
P60026 1.000 P60026 →
P52702 1.000 P52702 →
Q6TLI9 1.000 Q6TLI9 →
Q9GJU1 1.000 Q9GJU1 →
P20288 1.000 P20288 →
P61169 1.000 P61169 →
P61168 1.000 P61168 →
O73810 1.000 O73810 →
DRD1 D(1A) dopamine receptor 1.000 landscape →
O42384 1.000 O42384 →
P18901 1.000 P18901 →
Q16950 0.999 Q16950 →
P53453 0.999 P53453 →
Q25322 0.999 Q25322 →
Q19084 0.999 Q19084 →
Q91081 0.999 Q91081 →
O42385 0.999 O42385 →
O02213 0.999 O02213 →
Q95136 0.998 Q95136 →
P24628 0.998 P24628 →
P42288 0.998 P42288 →
P50130 0.997 P50130 →
Q6XXX9 0.997 Q6XXX9 →
Q25321 0.997 Q25321 →
P31390 0.996 P31390 →
O70528 0.996 O70528 →
Q2KNE5 0.996 Q2KNE5 →
Q18775 0.996 Q18775 →
Q6XXY0 0.996 Q6XXY0 →
O77680 0.995 O77680 →